SCHEMBL1444906

SCHEMBL1444906

CC(O)N(C(C)O)C(C)(N)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL300633 0.75 ALDH1A1 (0.32)
SCHEMBL7108226 0.74
Hydrochloric Acid SCHEMBL28532975 0.73 ALDH1A1 (0.30)
SCHEMBL115483 0.71 ALDH1A1 (0.33)
SCHEMBL10580135 0.70 TSHR (0.30)
Isopropyl Alcohol SCHEMBL258905 0.70 ALDH1A1 (0.50)
Isopropyl Alcohol SCHEMBL819479 0.70
SCHEMBL20870748 0.67
SCHEMBL2485264 0.67
SCHEMBL28164612 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3371239-A1 METHOD FOR PRODUCING AN AQUEOUS BINDER BASF SE (DE) 2018-09-12 EP claimed
EP-2964705-A1 CATIONIC PAINT ADDITIVES ALLNEX AUSTRIA GmbH (AT) 2016-01-13 EP claimed
WO-2014135466-A1 CATIONIC PAINT ADDITIVES ALLNEX AUSTRIA GMBH (AT) 2014-09-12 WO claimed
US-6596911-B2 Providing a mixture comprising water and a hydrocarbon; and contacting with onium compound and amine salt for inhibiting the formation of the hydrocarbon hydrates BAKER HUGHES INCORPORATION 2003-07-22 US claimed
US-6533960-B2 Forming alcohol FIRMENICH SA (CH) 2003-03-18 US claimed
US-11524935-B2 Methods for treating attention-deficit/hyperactivity disorder SK BIOPHARMACEUTICALS CO., LTD. (KR) 2022-12-13 US disclosed
US-20210070694-A1 METHODS FOR TREATING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER SK BIOPHARMACEUTICALS CO LTD (KR) 2021-03-11 US disclosed
US-10131938-B2 Method of designing addressable array suitable for detection of nucleic acid sequence differences using ligase detection reaction CORNELL RESEARCH FOUNDATION, INC. (US) 2018-11-20 US disclosed
US-20180002744-A1 METHOD OF DESIGNING ADDRESSABLE ARRAY SUITABLE FOR DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING LIGASE DETECTION REACTION CORNELL RES FOUNDATION INC (US) 2018-01-04 US disclosed
US-9725759-B2 Method of designing addressable array suitable for detection of nucleic acid sequence differences using ligase detection reaction CORNELL RESEARCH FOUNDATION, INC. (US) 2017-08-08 US disclosed
EP-2289512-B1 Pharmaceutical foam STIEFEL RES AUSTRALIA PTY LTD (AU) 2017-06-07 EP disclosed
US-20160215329-A1 METHOD OF DESIGNING ADDRESSABLE ARRAY SUITABLE FOR DETECTION OF NUCLEIC ACID SEQUENCE DIFFERENCES USING LIGASE DETECTION REACTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-07-28 US disclosed
US-5198473-A Polyether polyol BASF CORPORATION 1993-03-30 US disclosed
US-5141738-A Diagnosis medium; containing fatty acid SCHERING AKTIENGESELLSCHAFT (DE) 1992-08-25 US disclosed
EP-0179006-B1 PROCESS FOR THE PREPARATION OF THE FVIII/VWF COMPLEX FOR THERAPEUTICAL USE, AND RESULTING PRODUCTS IMMUNO FRANCE S.A.R.L. (FR) 1991-12-04 EP disclosed
EP-0179006-A1 Process for the preparation of the FVIII/vWF complex for therapeutical use, and resulting products IMMUNO FRANCE S.A.R.L. (FR) 1986-04-23 EP disclosed
WO-1986001718-A1 METHOD FOR OBTAINING THE COMPLEX FVIII/vWF OF THERAPEUTIC USE AND PRODUCTS RESULTING THEREFROM IMMUNOTECH (FR) 1986-03-27 WO disclosed
EP-0056475-A2 Pharmaceutical compositions MERCK PATENT GmbH (DE) 1982-07-28 EP disclosed
US-4248720-A COMPLEXES WITH HYDROCARBON SUBSTITUTED THIO-BIS-PHENOLS, USED IN HYDROCARBON FUELS, OILS EXXON RESEARCH & ENGINEERING CO. (US) 1981-02-03 US disclosed
US-3966775-A OXIDATION OF A 5-NITRO-1,4,4A,9A-TETRAHYDROQUINONE NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JA) 1976-06-29 US disclosed